Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
about
PID1 increases chemotherapy-induced apoptosis in medulloblastoma and glioblastoma cells in a manner that involves NFκB.Bortezomib Treatment Sensitizes Oncolytic HSV-1-Treated Tumors to NK Cell Immunotherapy.The ubiquitin-proteasome pathway in adult and pediatric brain tumors: biological insights and therapeutic opportunities.A phase 1 clinical trial evaluating marizomib, pomalidomide and low-dose dexamethasone in relapsed and refractory multiple myeloma (NPI-0052-107): final study results.
P2860
Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Marizomib activity as a single ...... cross the blood-brain barrier.
@en
type
label
Marizomib activity as a single ...... cross the blood-brain barrier.
@en
prefLabel
Marizomib activity as a single ...... cross the blood-brain barrier.
@en
P2093
P2860
P356
P1433
P1476
Marizomib activity as a single ...... cross the blood-brain barrier.
@en
P2093
Ann MacLaren
Daniela A Bota
Francis J Burrows
G Kenneth Lloyd
Mohit Trikha
Vivek Abraham
P2860
P304
P356
10.1093/NEUONC/NOV299
P577
2015-12-17T00:00:00Z